Search Results 691-700 of 17864 for monoclonal antibody

1. A Study to Evaluate Regorafenib with Cetuximab or Panitumumab to Treat Unresectable, Locally Advanced, or Metastatic Colorectal Cancer - Mayo Clinic

   Regorafenib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as cetuximab or panitumumab, ...

2. Autoimmune Diseases Clinical Trials - Mayo Clinic Research

   Ixekizumab is a recombinant high-affinity fully human monoclonal antibody that targets IL-17A Immunoglobulin gamma-1 (IgG1)/kappa-class. The purpose of this ...

3. Breast Cancer Clinical Trials - Mayo Clinic Research

   Monoclonal antibodies, such as atezolizumab, may block tumor growth in ... Denosumab is a monoclonal antibody that is used to treat bone loss in order ...

4. Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients with Refractory or Relapsed Indolent Non-Hodgkin Lymphoma - Mayo Clinic

   RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some find cancer cells and help kill them or carry cancer ...

5. Clinical Chemistry, Post Ph.D. Fellowship (Minnesota) - Meet The Faculty

   She is a laboratory director for the Protein Immunology, Antibody ... Her research interests span the areas of complement, monoclonal antibody therapies, ...

6. Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

7. Publications - Joseph D. Yao, M.D. - Mayo Clinic

   ... monoclonal antibody therapy in solid organ transplant recipients. J Med ... monoclonal antibody escape mutation in a persistently infected ...

8. A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Anti-N-Methyl-D-Aspartic Acid Receptor (NMDAR) Or Anti-Leucine-Rich Glioma-Inactivated 1 (LGI1) Encephalitis (Cielo) - Mayo Clinic

   * Any previous treatment with anti-CD19 antibody, complement inhibitors, neonatal Fc receptor antagonists, anti-B-lymphocyte stimulator monoclonal antibody * ...

9. Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery - Mayo Clinic

   Monoclonal antibodies, such as cetuximab and bevacizumab, may interfere with the ability of tumor cells to grow and spread. Giving irinotecan and cetuximab ...

10. Publications - Nikola A. Baumann, Ph.D. - Mayo Clinic

    Lack of observed interference by therapeutic monoclonal antibodies in select commonly utilized immunoassays. ... Antibody Detection Methods. J Clin ...